Escalon Medical Corp. (ESMC)
OTCMKTS · Delayed Price · Currency is USD
0.2500
+0.0100 (4.17%)
Feb 27, 2026, 12:05 PM EST

Escalon Medical Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
12.3112.0511.9812.1810.710.47
Revenue Growth (YoY)
1.17%0.54%-1.63%13.80%2.21%11.40%
Cost of Revenue
6.916.546.846.76.16.04
Gross Profit
5.45.515.155.484.614.43
Selling, General & Admin
4.84.624.564.184.093.57
Research & Development
0.80.750.690.820.990.89
Operating Expenses
5.65.385.2555.084.46
Operating Income
-0.20.13-0.10.48-0.47-0.03
Interest Expense
-0.02-0.02-0.02-0.02-0.02-0.02
Interest & Investment Income
----00
Other Non Operating Income (Expenses)
-0.03-0.01---0
EBT Excluding Unusual Items
-0.250.11-0.130.46-0.49-0.05
Other Unusual Items
----0.51-
Pretax Income
-0.250.11-0.130.460.02-0.05
Earnings From Continuing Operations
-0.250.11-0.130.460.02-0.05
Net Income
-0.250.11-0.130.460.02-0.05
Preferred Dividends & Other Adjustments
-0.010.080.050.240.050.05
Net Income to Common
-0.240.03-0.180.22-0.03-0.1
Net Income Growth
---2426.55%--
Shares Outstanding (Basic)
777777
Shares Outstanding (Diluted)
71471477
Shares Change (YoY)
-31.01%92.20%-45.33%82.92%--
EPS (Basic)
-0.030.00-0.020.03-0.00-0.01
EPS (Diluted)
-0.040.00-0.020.03-0.00-0.01
Free Cash Flow
-0.390.38-0.640.32-1.050.83
Free Cash Flow Per Share
-0.050.03-0.090.02-0.140.11
Gross Margin
43.87%45.75%42.95%45.00%43.04%42.28%
Operating Margin
-1.62%1.11%-0.87%3.93%-4.39%-0.32%
Profit Margin
-1.94%0.23%-1.48%1.82%-0.31%-0.99%
Free Cash Flow Margin
-3.20%3.13%-5.37%2.61%-9.81%7.92%
EBITDA
-0.170.17-0.060.52-0.420.01
EBITDA Margin
-1.35%1.42%-0.49%4.30%-3.94%0.11%
D&A For EBITDA
0.030.040.050.050.050.04
EBIT
-0.20.13-0.10.48-0.47-0.03
EBIT Margin
-1.62%1.11%-0.87%3.93%-4.39%-0.32%
Revenue as Reported
12.3112.0511.9812.1810.710.47
Advertising Expenses
-----0
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.